Upgrade to SI Premium - Free Trial

Rocket Pharmaceuticals (RCKT)

2.75 -0.17 (5.82%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/10/26)

Latest Headlines

Form SC TO-I/A ROCKET PHARMACEUTICALS, Filed by: ROCKET PHARMACEUTICALS, INC. May 28, 2026 5:51 PM - SEC Filing Form 4 ROCKET PHARMACEUTICALS, For: May 26 Filed by: Militello John May 28, 2026 5:13 PM - SEC Filing Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences May 28, 2026 7:00 AM - BizWire Form 4 ROCKET PHARMACEUTICALS, For: May 21 Filed by: Shah Gaurav May 26, 2026 7:47 PM - SEC Filing Form 4 ROCKET PHARMACEUTICALS, For: May 19 Filed by: Shah Gaurav May 21, 2026 4:07 PM - SEC Filing Form 4 ROCKET PHARMACEUTICALS, For: May 19 Filed by: Wilson Martin May 21, 2026 4:07 PM - SEC Filing Form 4 ROCKET PHARMACEUTICALS, For: May 19 Filed by: Militello John May 21, 2026 4:07 PM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Shah Gaurav May 21, 2026 3:41 PM - SEC Filing Form 8-K ROCKET PHARMACEUTICALS, For: May 20 May 21, 2026 6:04 AM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Shah Gaurav May 19, 2026 3:39 PM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Militello John May 19, 2026 3:34 PM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Wilson Martin May 19, 2026 3:20 PM - SEC Filing Form 4 ROCKET PHARMACEUTICALS, For: May 13 Filed by: Wilson Martin May 14, 2026 4:23 PM - SEC Filing Form 4 ROCKET PHARMACEUTICALS, For: May 13 Filed by: Shah Gaurav May 14, 2026 4:20 PM - SEC Filing Form 4 ROCKET PHARMACEUTICALS, For: May 13 Filed by: Militello John May 14, 2026 4:17 PM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Wilson Martin May 13, 2026 3:16 PM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Shah Gaurav May 13, 2026 3:13 PM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Militello John May 13, 2026 3:10 PM - SEC Filing Form 4 ROCKET PHARMACEUTICALS, For: May 07 Filed by: Chaudhuri Sarbani May 11, 2026 7:48 PM - SEC Filing Rocket Pharmaceuticals (RCKT) PT Raised to $15 at Cantor Fitzgerald May 8, 2026 8:07 AM - StreetInsider Rocket Pharmaceuticals (RCKT) Misses Q1 EPS by 2c May 7, 2026 5:54 PM - StreetInsider Form 8-K ROCKET PHARMACEUTICALS, For: May 07 May 7, 2026 4:47 PM - SEC Filing Form 10-Q ROCKET PHARMACEUTICALS, For: Mar 31 May 7, 2026 4:08 PM - SEC Filing Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress May 7, 2026 4:00 PM - BizWire Form 144 ROCKET PHARMACEUTICALS, Filed by: Chaudhuri Sarbani May 7, 2026 3:15 PM - SEC Filing Rocket Pharmaceuticals (RCKT) PT Raised to $12 at Leerink Partners April 28, 2026 9:20 AM - StreetInsider Form 8-K ROCKET PHARMACEUTICALS, For: Apr 26 April 28, 2026 7:35 AM - SEC Filing Rocket Pharmaceuticals sells priority review voucher for $180 million April 28, 2026 7:00 AM - StreetInsider Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher April 28, 2026 7:00 AM - BizWire Form SC TO-I ROCKET PHARMACEUTICALS, Filed by: ROCKET PHARMACEUTICALS, INC. April 27, 2026 9:43 AM - SEC Filing Form ARS ROCKET PHARMACEUTICALS, For: Dec 31 April 6, 2026 4:12 PM - SEC Filing Form DEFA14A ROCKET PHARMACEUTICALS, April 6, 2026 4:11 PM - SEC Filing Form DEF 14A ROCKET PHARMACEUTICALS, For: May 20 April 6, 2026 4:08 PM - SEC Filing Form SC TO-C ROCKET PHARMACEUTICALS, Filed by: ROCKET PHARMACEUTICALS, INC. April 3, 2026 8:31 AM - SEC Filing Rocket Pharmaceuticals (RCKT) PT Raised to $9 at BofA Securities March 27, 2026 4:20 PM - StreetInsider Rocket Pharmaceuticals (RCKT) PT Raised to $11 at Leerink Partners March 27, 2026 3:02 PM - StreetInsider Form SCHEDULE 13G/A ROCKET PHARMACEUTICALS, Filed by: VANGUARD GROUP INC March 27, 2026 1:00 PM - SEC Filing Morgan Stanley on Rocket Pharmaceuticals (RCKT): approval marks 'positive readthrough to broader pipeline' March 27, 2026 12:06 PM - StreetInsider Chardan Reiterates Buy Rating on Rocket Pharmaceuticals (RCKT) amid FDA accelerated approval March 27, 2026 12:00 PM - StreetInsider Form 8-K ROCKET PHARMACEUTICALS, For: Mar 26 March 27, 2026 7:33 AM - SEC Filing Rocket Pharmaceuticals receives FDA approval for rare disease gene therapy March 27, 2026 7:01 AM - StreetInsider Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I) March 27, 2026 7:00 AM - BizWire Form PRE 14A ROCKET PHARMACEUTICALS, For: May 20 March 25, 2026 6:03 AM - SEC Filing Form EFFECT ROCKET PHARMACEUTICALS, March 11, 2026 6:03 AM - SEC Filing Form 8-K ROCKET PHARMACEUTICALS, For: Mar 10 March 10, 2026 5:25 PM - SEC Filing Form 424B5 ROCKET PHARMACEUTICALS, March 10, 2026 5:20 PM - SEC Filing Full Article List